Concepedia

Linda B. Tabas

LB

17

Publications

1.1K

Citations

17

H-Index

1992

Active since

Affiliations

Eli Lilly (United States)(Current)

Indiana University School of Medicine

Indiana University – Purdue University Indianapolis

Linda B. Tabas is an author at Eli Lilly (United States) specializing in medicine, pharmacology, and drug resistance.

Top concepts

Publications per year

1992–2015

17

Publications

17

Association of Intestinal Peptide Transport with a Protein Related to the Cadherin Superfamily

Anne H. Dantzig, JoAnn Hoskins, Linda B. Tabas et al. · Science · 1994 · 179 citations

Selectivity of the Multidrug Resistance Modulator, LY335979, for P-Glycoprotein and Effect on Cytochrome P-450 Activities

Anne H. Dantzig, Robert L. Shepard, K L Law et al. · Journal of Pharmacology and Experimental Therapeutics · 1999 · 178 citations · Full text

Frontolimbic atrophy is associated with agitation and aggression in mild cognitive impairment and Alzheimer's disease

Paula T. Trzepacz, Peng Yu, Phani K. Bhamidipati et al. · Alzheimer s & Dementia · 2012 · 133 citations · Full text

Transport mechanisms responsible for the absorption of loracarbef, cefixime, and cefuroxime axetil into human intestinal Caco-2 cells

Anne H. Dantzig, Dale C. Duckworth, Linda B. Tabas · Biochimica et Biophysica Acta (BBA) - Biomembranes · 1994 · 71 citations

, , +7

Tricyclic isoxazoles are novel inhibitors of the multidrug resistance protein (MRP1)

Bryan H. Norman, Joseph M. Gruber, Sean P. Hollinshead et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 66 citations · Full text

, , +11

Rows per page

1–5 of 17